Atlas Trials

Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

Clinical trial NCT02757989 · COMPLETED

Trial details

NCT number
NCT02757989
Sponsor
Groupe Francophone des Myelodysplasies
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
MDS
Start date
2016-05-31
Primary completion
2024-06-07
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.